Авторы

  • Anorboev M., Mullokulov J.
  • Akromov I.

Ключевые слова:

rheumatoid arthritis; total knee arthroplasty; cytokines; TNF-α; IL-6; IL-1β; personalized therapy; real-world evidence.

Библиографические ссылки

1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–2038.DOI: 10.1016/S0140-6736(16)30173-8 https://pubmed.ncbi.nlm.nih.gov/27156434/

2. Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the GBD 2010 study. Ann Rheum Dis. 2014;73:1316–1322. DOI: 10.1136/annrheumdis-2013-204627 https://pubmed.ncbi.nlm.nih.gov/24550173/

3. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–2219. DOI: 10.1056/NEJMra1004965 https://pubmed.ncbi.nlm.nih.gov/22150039/

4. Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis. Arthritis Rheum. 1998; 41: 1072–1082. DOI: 10.1002/1529-0131(199806)41:6<1072::AID-ART22>3.0.CO;2-Jpubmed.ncbi.nlm.nih.gov/9627013/

5. Goodman SM, Figgie M. Arthroplasty in patients with rheumatoid arthritis. Rheum Dis Clin North Am. 2013; 39:411–425.DOI: 10.1016/j.rdc.2013.02.002 https://pubmed.ncbi.nlm. nih.gov/23782805/

6. Ethgen O, Bruyère O, Richy F, et al. Health-related quality of life after total knee arthroplasty. J Bone Joint Surg Am. 2004;86:963–970.DOI: 10.2106/00004623-200405000-00006 https://pubmed.ncbi.nlm.nih.gov/15118039/

7. Bongartz T, Halligan CS, Osmon DR, et al. Incidence and risk factors of prosthetic joint infection in RA. Arthritis Rheum. 2008; 59:1713–1720.DOI: 10.1002/art.24060 https://pubmed. ncbi.nlm.nih.gov/19035431/

8. Cordtz RL, Zobbe K, Højgaard P, et al. Risk of prosthetic joint infection in RA. Ann Rheum Dis. 2018; 77: 281–289. DOI: 10.1136/annrheumdis-2017-211872 https://pubmed.ncbi.nlm. nih.gov/28974520/

9. Firestein GS, McInnes IB. Immunopathogenesis of RA. Immunity. 2017;46:183–196.DOI: 10.1016/j.immuni.2017.02.006 https://pubmed.ncbi.nlm.nih.gov/28228278/

10. Feldmann M, Maini RN. Role of cytokines in RA. Immunol Rev. 2008;223:7–19.DOI: 10.1111/j.1600-065X.2008.00600.x https://pubmed.ncbi.nlm.nih.gov/18613827/

11. Choy EHS, Panayi GS. Cytokine pathways in RA. N Engl J Med. 2001;344:907–916.DOI: 10.1056/NEJM200103223441207https://pubmed.ncbi.nlm.nih.gov/11259725/

12. Di Paolo NC, Shayakhmetov DM. Interleukin-1β in immunity and inflammation. Nat Rev Immunol. 2016;16:623–635.DOI: 10.1038/nri.2016.99 https://pubmed.ncbi.nlm.nih.gov/27648835/

13. Dewar DC, Filer A. The role of IL-6 in inflammation and autoimmunity. Br J Haematol. 2019;184:274–285.DOI: 10.1111/bjh.15663 https://pubmed.ncbi.nlm.nih.gov/30485471/

14. Singh JA, Saag KG, Bridges SL Jr, et al. 2015 ACR RA guideline. Arthritis Rheumatol. 2016;68:1–26.DOI: 10.1002/art.39480https://pubmed.ncbi.nlm.nih.gov/26545825/

15. Smolen JS, Landewé R, Bijlsma J, et al. EULAR 2019 update. Ann Rheum Dis. 2020; 79:685–699.DOI: 10.1136/annrheumdis-2019-216655 https://pubmed.ncbi.nlm.nih.gov/31969328/